An animal study (30) demonstrated that melatonin treatment significantly improved hyperglycemia in T2DM rat models by reducing insulin levels, inhibiting hemoglobin glycation, and ameliorating insulin resistance. This evidence concerns the gene INS and type 2 diabetes mellitus.